Evidence map›Paper›PMID 42373667›Full record

ArticleNature communications2026

Emergence of fibrotic pericytes and their transcriptional regulation in pulmonary fibrosis.

Wen Gao, Ying-Wei Lan, Zicheng Deng, Enhong Li, Anusha Acharya, Jonathan Do, Xiaomei Xia, Nicole Marquez, Danli Lu, Ali Al Siraj and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Wen GaoPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.ORCID http://orcid.org/0000-0002-7241-7900
Ying-Wei LanPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.
Zicheng DengPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.ORCID http://orcid.org/0000-0001-6868-7927
Enhong LiPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.
Anusha AcharyaCollege of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Jonathan DoPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.ORCID http://orcid.org/0009-0003-5043-2936
Xiaomei XiaPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.
Nicole MarquezPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.
Danli LuPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.
Ali Al SirajPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.
Nicholas E BanovichDivision of Bioinnovation and Genome Sciences, The Translational Genomics Research Institute (TGen), Phoenix, Arizona, USA.ORCID http://orcid.org/0000-0003-2604-3247
Angara SureshbabuNorton Thoracic Institute, St. Joseph's Hospital and Medical Center, Dignity Health, Phoenix, Arizona, USA.
Ross BremnerNorton Thoracic Institute, St. Joseph's Hospital and Medical Center, Dignity Health, Phoenix, Arizona, USA.
Vladimir V KalinichenkoPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA.ORCID http://orcid.org/0000-0003-3438-2660
Tanya V KalinPhoenix Children's Research Institute, Department of Child Health, College of Medicine Phoenix, University of Arizona, Phoenix, Arizona, USA. tatianakalin@arizona.edu.ORCID http://orcid.org/0000-0002-8545-8277

Funding

Role of lung endothelial cells during fibrotic lung remodeling.R01HL158659 · NHLBI · UNIVERSITY OF ARIZONA · PI KALIN, TANYA · 2021 to 2024
$2.2M
Theraputic targeting of pulmonary endothelial cells to inhibit pathological lung remodelingR01HL177800 · NHLBI · UNIVERSITY OF ARIZONA · PI Tanya Kalin · 2025 to 2026
$1.4M
NHLBI NIH HHS R01 HL158659NHLBI NIH HHS R01 HL177800U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL158659U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL177800
6 · The paper itself

Abstract

Multiple cell types have been implicated in pathogenesis of pulmonary fibrosis with pericytes emerging as a new focus due to their role in promoting fibrotic remodeling. Fibrotic environment changes normal pericyte functions, but transcriptional programs regulating pericyte transition towards fibrotic state remain unclear. Utilizing single cell RNA-sequencing of human pulmonary fibrotic lungs and mouse genetic models, we identified a unique cluster of fibrosis-associated pericytes which was not present in normal lungs and exhibited a distinctive transcriptional signature indicating transition of normal pericytes to a fibrotic state. FOXF1 was identified as one of the transcription factors decreased in fibrotic pericytes. Pericyte-specific deletion of Foxf1 increased severity of pulmonary fibrosis in bleomycin mouse model as demonstrated by reduced survival, impaired lung functions, increased body weight loss and increased fibrotic remodeling. Pericyte-specific overexpression of Foxf1 attenuated pulmonary fibrosis, reversed fibrotic changes and improved survival outcomes. Based on single cell RNA-sequencing and chromatin immunoprecipitation sequencing, FOXF1 transcriptionally regulates an extensive pericyte signaling network critical for pulmonary fibrosis. In vitro, FOXF1 transcriptionally activated ID3 which inhibited fibroblast activation through decreased secretion of IL8 and CXCL1 by pericytes. Altogether, FOXF1 prevents transition of pericytes to a fibrotic state, suggesting new therapeutic opportunities for treatment of pulmonary fibrosis.

Indexed as

Forkhead Transcription FactorsGene Expression RegulationPericytesPulmonary FibrosisAnimalsBleomycinDisease Models, AnimalFibroblastsHumansLungMaleMiceMice, Inbred C57BLSignal TransductionSingle-Cell Gene Expression AnalysisTranscription, GeneticBleomycinForkhead Transcription FactorsFoxf1 protein, mouse

Identifiers

PMID42373667
PMCPMC13458056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.